Prestige Consumer Healthcare (PBH) Shares Outstanding (Diluted Average) (2010 - 2025)

Prestige Consumer Healthcare (PBH) recorded quarterly Shares Outstanding (Diluted Average) of $48.1 million in Q4 2025, down 2.39% quarter-over-quarter from $49.3 million in Q3 2025, and down 3.81% on a YoY basis from $50.0 million in Q4 2024.

Prestige Consumer Healthcare (PBH) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Shares Outstanding (Diluted Average) history runs 16 years deep, the most recent figure standing at $48.1 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Diluted Average) fell 3.81% year-over-year to $48.1 million; the TTM figure through Dec 2025 stood at $48.1 million (down 3.81% YoY), while the FY2025 annual figure was $50.1 million, changed 0.2% from the prior year.
  • Shares Outstanding (Diluted Average) was $48.1 million for Q4 2025 at Prestige Consumer Healthcare, down from $49.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $50.8 million in Q1 2022 to a low of $48.1 million in Q4 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $50.2 million across 5 years, with a median of $50.2 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) climbed 0.58% in 2024, then retreated 3.81% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $50.8 million in 2021, then declined by 0.8% to $50.4 million in 2022, then slipped by 0.51% to $50.1 million in 2023, then retreated by 0.28% to $50.0 million in 2024, then fell by 3.81% to $48.1 million in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $48.1 million (Q4 2025), $49.3 million (Q3 2025), and $49.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Prestige Consumer Healthcare 2.37 Bn 2.31 Bn 157.37 Mn 48.09 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 48.09 Mn
Sep 30, 2025 49.26 Mn
Jun 30, 2025 49.83 Mn
Mar 31, 2025 50.08 Mn
Dec 31, 2024 49.99 Mn
Sep 30, 2024 50.00 Mn
Jun 30, 2024 50.27 Mn
Mar 31, 2024 50.18 Mn
Dec 31, 2023 50.13 Mn
Sep 30, 2023 50.14 Mn
Jun 30, 2023 50.20 Mn
Mar 31, 2023 49.89 Mn
Dec 31, 2022 50.39 Mn
Sep 30, 2022 50.50 Mn
Jun 30, 2022 50.73 Mn
Mar 31, 2022 50.84 Mn
Dec 31, 2021 50.80 Mn
Sep 30, 2021 50.79 Mn
Jun 30, 2021 50.67 Mn
Mar 31, 2021 50.61 Mn